Last reviewed · How we verify
ESAT6-CFP10
At a glance
| Generic name | ESAT6-CFP10 |
|---|---|
| Also known as | Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10, EC |
| Sponsor | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
- Diagnosis of Tuberculosis in Swiss Children
- Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers (NA)
- Clinical Study of BCG Vaccine for Intradermal Injection (PHASE1)
- A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (PHASE1)
- Diagnosing of Acute Tuberculosis
- Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy) (PHASE3)
- Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |